The Role of OPSYNVI® in PAH treatment goals : From Early risk reduction to Sustained low‑risk status / Dae-Hee Kim (Univ. of Ulsan, Korea)

Clinical Efficacy of OPSYNVI® Compared with Monotherapy : Clinical evidence and Real-world practice in PAH / Jung Hyun Choi (Pusan National Univ., Korea)